Use of peptides combine with nanotechnology and molecular imaging - New tools for diagnosis and treatment of neuropsychiatric disorders

Revista Brasileira de Psiquiatria

Volumn 31, Issue 4, 2009, Pages 300-302

  Malavolta, Luciana ^a   Cabral, Francisco Romero ^a   Fernel, Lionel ^a   Conterras, Gamarra ^a   Ringheim, Anna Maria ^a   Bressan, Rodrigo Affonseca ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BLOOD CLOTTING FACTOR 7; BOMBESIN A TC 99M; DRUG CARRIER; GRP RECEPTOR; INSULIN; METAL NANOPARTICLE; NANOPARTICLE; NC 1900; NEUROTRANSMITTER; NK1 RECEPTOR; PEPTIDE; PEPTIDE HORMONE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RECEPTOR; SUBSTANCE P; THYROID HORMONE; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; DIAGNOSTIC AGENT;

AGGRESOME; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANOREXIA; ANXIETY; BEHAVIOR CHANGE; BINDING AFFINITY; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CELL ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; COLLOID; DIABETES MELLITUS; DRUG ABUSE; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SELECTIVITY; EDITORIAL; GENE OVEREXPRESSION; GOITER; HUMAN; HYDROGEN BOND; HYDROPHILICITY; LEARNING; LIPOPHILICITY; MAGNETIC FIELD; MEMORY; MENTAL DISEASE; MOLECULAR IMAGING; MOLECULAR WEIGHT; NANOTECHNOLOGY; NEUROMODULATION; NEUROTRANSMISSION; NUTRIENT; PAIN; PARKINSON DISEASE; PHYSICAL CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN STABILITY; PSYCHIATRIC DIAGNOSIS; RETICULOENDOTHELIAL SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP; STRESS; THERMOREGULATION; METHODOLOGY;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MENTAL DISORDERS; MOLECULAR IMAGING; NANOTECHNOLOGY; PEPTIDES;

EID: 77149130524     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462009000400003     Document Type: Editorial

References (5)

1. Gentilucci L, Tolomelli A, Squassabia F. Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr Med Chem. 2006;13(7):2449-66.
2. Brasnjevic I, Steinbusch, HW, Schmitz C, Martinez-Martinez P; European NanoBioPharmaceutics Research Initiative. Delivery of peptide and protein drugs over the blood-brain barrier. Progr Neurobiol. 2009;87(4):212-51.
3. Reubi JC, Mäcke HR, Krenning EP. Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med. 2005;46(SuplI):67S-75S.
4. Bressan RA, Shih MC, Hoexter MQ, Lacerda AL. Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders? Rev Bras Psiquiatr. 2007;29(2):102-4.
5. Kurihara A, Pardridge WM. Aβ1-40 peptide radiopharmaceuticals for brain amyloid imaging: 111In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections. Bioconjug Chem. 2000;11(3):380-6.